1
|
Butany J, Schoen FJ. Cardiac valve replacement and related interventions. Cardiovasc Pathol 2022. [DOI: 10.1016/b978-0-12-822224-9.00010-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
2
|
|
3
|
Bioprosthetic Heart Valve Calcification: Clinicopathologic Correlations, Mechanisms, and Prevention. CONTEMPORARY CARDIOLOGY 2020. [DOI: 10.1007/978-3-030-46725-8_9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
4
|
Lootens L, Verbeke J, Martens T, Philipsen T, Caes F, Van Belleghem Y, Van Nooten G, François K, De Bacquer D, Bove T. Ten-year results of aortic valve replacement with first-generation Mitroflow bioprosthesis: is early degeneration a structural or a technical issue? Eur J Cardiothorac Surg 2018; 52:272-278. [PMID: 28430883 DOI: 10.1093/ejcts/ezx117] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Accepted: 03/04/2017] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVES Concerns have been raised about the durability of the first-generation Mitroflow aortic bioprosthesis (model 12 A-LX) due to the lack of anticalcification treatment. This study reflects a 10-year experience with this prosthesis for aortic valve replacement. METHODS From June 2003 to May 2012, the Mitroflow prosthesis was used for aortic valve replacement in 510 patients, of whom only 467 with complete clinical follow-up were included for analysis. Study end-points were survival and incidence of structural valve degeneration (SVD). Analysis of SVD was based on cumulative incidence function and competing-risk Cox regression. RESULTS The mean patient age was 76.4 ± 6.1 years. Valve sizes from 23 to 25 were used in 70.4%, whereas sizes from 19 to 21 were used in only 19.2%, thereby avoiding patient-prosthesis mismatch in 89.1%. Within a median follow-up time of 6.6 years (interquartile range 4.4), a cumulative 2375 patient-years, the survival rate was 86.2%, 67.3% and 33.3% at 1, 5 and 10 years, respectively. The cumulative incidence of SVD, with death as a competing risk, was 0%, 0.7% and 6.2% at 1, 5 and 10 years, respectively. Only age <75 years tended to affect the late hazard of SVD (hazard ratio 0.50, 95% confidence interval 0.23-1.08, P = 0.08), regardless of valve-specific issues. CONCLUSIONS The data do not support the concerns about early accelerated structural degeneration of the first-generation Mitroflow bioprosthesis used for aortic valve replacement in patients older than 75 years. We postulate that limiting the number of small prostheses using a proper implantation technique has enhanced the reduction in risk of significant patient-prosthesis mismatch as the main determinant of early SVD.
Collapse
Affiliation(s)
- Liesbeth Lootens
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Jonas Verbeke
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Thomas Martens
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Tine Philipsen
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Frank Caes
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Yves Van Belleghem
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Guido Van Nooten
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Katrien François
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| | - Dirk De Bacquer
- Department of Biostatistics, University of Ghent, Ghent, Belgium
| | - Thierry Bove
- Department of Cardiac Surgery, University Hospital of Ghent, Ghent, Belgium
| |
Collapse
|
5
|
Jiang WJ, Cui YC, Li JH, Zhang XH, Ding HH, Lai YQ, Zhang HJ. Is autologous or heterologous pericardium better for valvuloplasty? A comparative study of calcification propensity. Tex Heart Inst J 2015; 42:202-8. [PMID: 26175630 DOI: 10.14503/thij-14-4296] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Pericardial calcification is detrimental to the long-term durability of valvuloplasty. However, whether calcification susceptibility differs between heterologous and autologous pericardium is unclear. In this study, we compared the progression of calcification in vivo between autologous and heterologous pericardium. We randomly divided 28 rabbits into 4 equal groups. Resected rabbit pericardium served as autologous pericardium, and commercial bovine pericardium served as heterologous pericardium. We subcutaneously embedded one of each pericardial patch in the abdominal walls of 21 of the rabbits. The 7 control rabbits (group A) received no implants. The embedded samples were removed at 2 months in group B, at 4 months in group C, and at 6 months in group D. Each collected sample was divided into 2 parts, one for calcium-content measurement by means of atomic-absorption spectroscopy, and one for morphologic and histopathologic examinations. When compared with the autologous pericardium, calcium levels in the heterologous pericardium were higher in groups B, C, and D (P <0.0001, P <0.0002, and P <0.0006, respectively). As embedding time increased, calcium levels in the heterologous pericardium increased faster than those in the autologous, especially in group D. Disorganized arrangements of collagenous fibers, marked calculus, and ossification were seen in the heterologous pericardium. Inflammatory cells-mainly lymphocytes and small numbers of macrophages-infiltrated the heterologous pericardium. The autologous pericardium showed a stronger ability to resist calcification. Our results indicate that autologous pericardium might be a relatively better choice for valvuloplasty.
Collapse
|
6
|
Abstract
The use of bioprosthetic valves fabricated from fixed heterograft tissue (porcine aortic valves or bovine pericardium) in heart valve replacement surgery is limited because of calcification-related failures. The mechanism of calcification of bioprosthetic valves is quite complex and has a variety of determinants, including host factors, tissue fixation conditions, and mechanical effects. Currently, there is no effective therapy to prevent calcification in clinical settings. This article reviews a variety of anticalcification strategies that are under investigation either in advanced animal models or in clinical trials. Bisphosphonates, such as ethan hydroxybisphosphonate (EHBP), inhibit calcium phosphate crystal formation. However, because of their systemic toxicity, they are used as either tissue treatments or polymeric site-specific delivery systems. Detergent treatment, such as sodium dodecyl sulfate (SDS), extracts almost all phospholipids from bioprosthetic heart valve cuspal tissue. Procedures, such as amino oleic acid pretreatment, inhibit calcium uptake. Polyurethane trileaflet valves, investigated as alternatives to bioprosthetic or mechanical valve prostheses, undergo intrinsic and thrombus-related calcification and degradation. Calcification- and thrombus-resistant polyurethanes synthesized in our laboratory by covalent linking of EHBP or heparin (either in bulk or on surface) by unique polyepoxidation chemistry are attractive candidates for further research. Tissue-engineered heart valves may have an important place in the future.
Collapse
|
7
|
Schoen FJ. Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc Pathol 2015; 4:241-55. [PMID: 25851087 DOI: 10.1016/1054-8807(95)00051-6] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/1995] [Accepted: 06/07/1995] [Indexed: 11/29/2022] Open
Abstract
Pathologists are likely to encounter substitute heart valves with increasing frequency. Informed evaluation of such valves provides valuable information that contributes to both patient care and our understanding of the pathobiology of host interactions with mechanical devices. This article summarizes the most important considerations underlying such analyses-including valve identification, common morphologic features and modes of failure, technical details of evaluation, and potential pitfalls.
Collapse
Affiliation(s)
- F J Schoen
- Department of Pathology, Brigham and Women's Hospital Boston, Massachusetts, U.S.A.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, U.S.A
| |
Collapse
|
8
|
Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J Thorac Cardiovasc Surg 2014; 147:1219-24. [DOI: 10.1016/j.jtcvs.2013.03.025] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2012] [Revised: 12/15/2012] [Accepted: 03/15/2013] [Indexed: 11/21/2022]
|
9
|
Transesophageal Echocardiography in Healthy Young Adult Male Baboons ( Papio hamadryas anubis): Normal Cardiac Anatomy and Function in Subhuman Primates Compared to Humans. PROGRESS IN PEDIATRIC CARDIOLOGY 2013; 35:109-120. [PMID: 24707162 DOI: 10.1016/j.ppedcard.2013.09.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Implantable, viable tissue engineered cardiovascular constructs are rapidly approaching clinical translation. Species typically utilized as preclinical large animal models are food stock ungulates for which cross species biological and genomic differences with humans are great. Multiple authorities have recommended developing subhuman primate models for testing regenerative surgical strategies to mitigate xenotransplant inflammation. However, there is a lack of specific quantitative cardiac imaging comparisons between humans and the genomically similar baboons (Papio hamadryas anubis). This study was undertaken to translate to baboons transesophageal echocardiographic functional and dimensional criteria defined as necessary for defining cardiac anatomy and function in the perioperative setting. Seventeen young, healthy baboons (approximately 30 kg, similar to 5 year old children) were studied to determine whether the requisite 11 views and 52 measurement parameters could be reliably acquired by transesophageal echocardiography (TEE). The obtained measurements were compared to human adult normative literature values and to a large relational database of pediatric "normal heart" echo measurements. Comparisons to humans, when normalized to BSA, revealed a trend in baboons toward larger mitral and aortic valve effective orifice areas and much larger left ventricular muscle mass and wall thickness, but similar pulmonary and tricuspid valves. By modifying probe positioning relative to human techniques, all recommended TEE views except transgastric could be replicated. To supplement, two transthoracic apical views were discovered that in baboons could reliably replace the transgastric TEE view. Thus, all requisite echo views could be obtained for a complete cardiac evaluation in Papio hamadryas anubis to noninvasively quantify cardiac structural anatomy, physiology, and dimensions. Despite similarities between the species, there are subtle and important physiologic and anatomic differences when compared to human.
Collapse
|
10
|
|
11
|
Schoen FJ, Levy RJ. Pathological Calcification of Biomaterials. Biomater Sci 2013. [DOI: 10.1016/b978-0-08-087780-8.00063-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Ruzza A, Vespignani R, Khoynezhad A, Berci G, De Robertis M, Trento A, Czer LSC. Concomitant dual intravascular and subcutaneous microsurgical implantation of xenograft tissue in a rodent model for evaluation of structural degeneration. Transplant Proc 2012; 45:735-40. [PMID: 23267809 DOI: 10.1016/j.transproceed.2012.06.061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Revised: 05/26/2012] [Accepted: 06/19/2012] [Indexed: 10/27/2022]
Abstract
INTRODUCTION An economical animal model to study xenograft tissue degeneration and calcification and the durability of biological vascular patch material and bioprosthetic valve leaflets is desirable. OBJECTIVE A cost-effective model to analyze xenograft degeneration, calcification, immunologic reaction, and anticalcification treatment was developed. Furthermore, a technique for implant into the vascular lumen of the abdominal aorta in rats is presented. METHODS Twelve Lewis rats were used as recipients. The microsurgical procedure was performed using a high-definition optical system. Anesthesia was induced and maintained with isoflurane inhalation. The suprarenal and infrarenal portion of the abdominal aorta was isolated, the abdominal aorta was cross-clamped, and a 4-mm square portion of the abdominal aorta was removed. Subsequently, a complementary-sized piece of porcine or bovine glutaraldehyde-fixed bioprosthetic valve leaflet tissue was sutured as a patch in the abdominal aorta. RESULTS The mean operating time was 45 ± 10 minutes and the mean ischemic time was 25 ± 5 minutes. Early and 3-month survivals were 100%. One rat had intraoperative bleeding. No paralysis or thrombosis was observed. CONCLUSION Feasibility and reproducibility of removing a portion of the abdominal aorta and replacing it with a patch of xenograft tissue was demonstrated in a rodent model with 100% survival at 3 months. Concomitant dual intravascular and subcutaneous microsurgical implantation of xenograft tissue in a small-animal (rat) model is a cost-effective approach for investigation of xenograft tissue degeneration.
Collapse
Affiliation(s)
- A Ruzza
- Division of Cardiothoracic Surgery, Cedars-Sinai Heart Institute, the Comprehensive Transplant Center, Los Angeles, California 90048, USA
| | | | | | | | | | | | | |
Collapse
|
13
|
|
14
|
Kuan YH, Dasi LP, Yoganathan A, Leo HL. Recent Advances in Polymeric Heart Valves Research. ACTA ACUST UNITED AC 2011. [DOI: 10.4018/ijbre.2011010101] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Heart valve replacement is fast becoming a routine surgery worldwide, and heart valve prostheses are today considered among the most widely used cardiovascular devices. Mechanical and bioprostheses have been the traditional choices to the replacement surgeries. However, such valves continue to expose patients to risks including thrombosis, infection and limited valve durability. In recent years, advances in polymer science give rise to an important new class of artificial heart valve made predominantly of polyurethane-based materials, which show improved biocompatibility and biostability. These polymeric heart valves have demonstrated excellent hemodynamic performance and good durability with excellent fatigue stress resistance. Advancements in the designs and manufacturing methods also suggested improved in the durability of polymeric heart valves. Animal studies with these valves have also shown good biocompatibility with minimal calcification of the valve leaflets. With these promising progresses, polymeric heart valves could be a viable alternative in the heart valve replacement surgeries in the near future.
Collapse
|
15
|
Ota T, Taketani S, Iwai S, Miyagawa S, Furuta M, Hara M, Uchimura E, Okita Y, Sawa Y. Novel method of decellularization of porcine valves using polyethylene glycol and gamma irradiation. Ann Thorac Surg 2007; 83:1501-7. [PMID: 17383366 DOI: 10.1016/j.athoracsur.2006.11.083] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2006] [Revised: 11/27/2006] [Accepted: 11/28/2006] [Indexed: 10/23/2022]
Abstract
BACKGROUND Recent tissue-engineered valves are in need of a breakthrough to overcome several limitations against clinical applications. We have developed a new method of decellularization using polyethylene glycol and gamma irradiation. METHODS Fresh porcine aortic valves were decellularized using polyethylene glycol and gamma irradiation. These were evaluated by histologic, biochemical (DNA, solubilized protein and collagen content), mechanical (strength test, transmission electron microscopy) and immunologic (porcine endogenous retrovirus and the alpha-1.3 galactosyl epitope) analyses. Implantations into the subcutaneous tissue of rats (1 week, n = 10; 2 months, n = 10) and into the descending aorta of dogs (2 months, n = 6; 6 months, n = 3) were used as in vivo studies. RESULTS Complete decellularization was confirmed by histologic examination and by determining the DNA and solubilized protein content. The decellularized valve showed no significant differences in its mechanical strength or collagen content compared with native porcine tissues. The ultrastructure was well preserved in transmission electron microscope images. The DNA sequence of a porcine endogenous retrovirus and the alpha-1.3 galactosyl epitope were eliminated after the decellularizing process. No acute rejection and little calcification was noted in the rat model. In the dog model at 2 months, the surface of the graft was completely covered with a monolayer of endothelial cells. In addition, several layers of vimentin-positive cells lay under the endothelial cells. At 6 months after implantation, many smooth muscle cells, monolayer endothelial cells, and some vasculogenesis were seen. CONCLUSIONS The decellularizing method provided low immunogenicity, low risk of unknown infections, and was little subject to calcification. The decellularized tissues showed acceptable durability and recellularization.
Collapse
Affiliation(s)
- Takeyoshi Ota
- Department of Cardiovascular Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. Tissue valve calcification is initiated primarily within residual cells that have been devitalized, usually by glutaraldehyde pretreatment. The mechanism involves reaction of calcium-containing extracellular fluid with membrane-associated phosphorus to yield calcium phosphate mineral deposits. Calcification is accelerated by young recipient age, valve factors such as glutaraldehyde fixation, and increased mechanical stress. Recent studies have suggested that pathologic calcification is regulated by inductive and inhibitory factors, similar to the physiologic mineralization of bone. The most promising preventive strategies have included binding of calcification inhibitors to glutaraldehyde fixed tissue, removal or modification of calcifiable components, modification of glutaraldehyde fixation, and use of tissue cross linking agents other than glutaraldehyde. This review summarizes current concepts in the pathophysiology of tissue valve calcification, including emerging concepts of endogenous regulation, progress toward prevention of calcification, and issues related to calcification of the aortic wall of stentless bioprosthetic valves.
Collapse
Affiliation(s)
- Frederick J Schoen
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, the Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts 02115, USA.
| | | |
Collapse
|
17
|
Clark JN, Ogle MF, Ashworth P, Bianco RW, Levy RJ. Prevention of Calcification of Bioprosthetic Heart Valve Cusp and Aortic Wall With Ethanol and Aluminum Chloride. Ann Thorac Surg 2005; 79:897-904. [PMID: 15734402 DOI: 10.1016/j.athoracsur.2004.08.084] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/30/2004] [Indexed: 11/24/2022]
Abstract
BACKGROUND Calcification is frequently associated with device failure of bioprostheses fabricated from either glutaraldehyde pretreated porcine aortic valves or bovine pericardium. It was hypothesized that differential pretreatment with ethanol-aluminum chloride will prove safe and efficacious for inhibiting the calcification of both the porcine aortic valve bioprosthetic cusp and the aortic wall. METHODS Glutaraldehyde-fixed porcine aortic valves were subjected to differential aluminum chloride (AlCl3) and ethanol pretreatment; aortic wall segments were treated exclusively with AlCl3 (0.1 moles/L) for 45 minutes, 6 hours, or 8 hours (groups 3A, B, and C, respectively), followed by valve cusp incubations in ethanol (80%, pH 7.4). Nontreated control bioprosthetic valves were either stent-mounted porcine aortic valve bioprostheses (Carpentier-Edwards, group 1) (Edwards, Santa Anna, CA) or St. Jude Toronto SPV valves (St. Jude Medical, St. Paul, MN) (group 2). Mitral valve replacements were carried out in juvenile sheep for 150 days. RESULTS Calcium in cusps from group 3A was 2.84 +/- 0.62 mg calcium/g tissue versus control, 22.79 +/- 8.46 mg calcium/g tissue, p = 0.04. Valves pretreated with AlCl3 for 45 minutes, 6 hours, and 8 hours had significantly lower levels of calcium in the aortic wall compared to controls (40.38 +/- 5.66, 26.77 +/- 4.02, and 28.94 +/- 8.25 mg calcium/g tissue for groups 3A, 3B, and 3C, respectively, vs 95.47 +/- 17.14 mg calcium/g tissue for group 1, p < 0.001, and 133.42 +/- 3.96 mg calcium/g tissue for group 2, p < 0.001). CONCLUSIONS Differentially applied ethanol and aluminum chloride pretreatment significantly inhibited calcification of both the glutaraldehyde-fixed porcine aortic valve bioprosthetic cusp and the aortic wall.
Collapse
Affiliation(s)
- Jocelyn N Clark
- Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA
| | | | | | | | | |
Collapse
|
18
|
Puskas JE, Chen Y. Biomedical Application of Commercial Polymers and Novel Polyisobutylene-Based Thermoplastic Elastomers for Soft Tissue Replacement†. Biomacromolecules 2004; 5:1141-54. [PMID: 15244424 DOI: 10.1021/bm034513k] [Citation(s) in RCA: 212] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Novel polyisobutylene-based thermoplastic elastomers are introduced as prospective implant materials for soft tissue replacement and reconstruction. In comparison, poly(ethylene terephthalate) (PET), poly(tetrafluoroethylene) (PTFE), polypropylene (PP), polyurethanes (PU), and silicones are outlined from well-established implant history as being relatively inert and biocompatible biomaterials for soft tissue replacement, especially in vascular grafts and breast implants. Some general considerations for the design and development of polymers for soft tissue replacement are reviewed from the viewpoint of material science and engineering, with special attention to synthetic materials used in vascular grafts and breast implants.
Collapse
Affiliation(s)
- Judit E Puskas
- Department of Chemical & Biochemical Engineering, The University of Western Ontario, London, Ontario, Canada N6A 5B9
| | | |
Collapse
|
19
|
Choo SJ, Kim KI, Park NH, Song JM, Choi IC, Shim JY, Lee SK, Kwon YJ, Kim CN, Lee JW. Development of an animal experimental model for a bileaflet mechanical heart valve prosthesis. J Korean Med Sci 2004; 19:37-41. [PMID: 14966339 PMCID: PMC2822261 DOI: 10.3346/jkms.2004.19.1.37] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The objective of this study was to develop a pre-clinical large animal model for the in vivo hemodynamic testing of prosthetic valves in the aortic position without the need for cardiopulmonary bypass. Ten male pigs were used. A composite valved conduit was constructed in the operating room by implanting a prosthetic valve between two separate pieces of vascular conduits, which bypassed the ascending aorta to the descending aorta. Prior to applying a side-biting clamp to the ascending aorta for proximal grafting to the aortic anastomosis, an aorta to femoral artery shunt was placed just proximally to this clamp. The heart rate, cardiac output, Vmax, transvalvular pressure gradient, effective orifice area and incremental dobutamine stress response were assessed. A dose-dependent increase with dobutamine was seen in terms of cardiac output, Vmax, and the peak transvalvular pressure gradient both in the native and in the prosthetic valve. However, the increment was much steeper in the prosthetic valve. No significant differences in cardiac output were noted between the native and the prosthetic valves. The described pre-clinical porcine model was found suitable for site-specific in-vivo hemodynamic assessment of aortic valvular prosthesis without cardiopulmonary bypass.
Collapse
Affiliation(s)
- Suk Jung Choo
- Department of Thoracic & Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Kun Il Kim
- Department of Thoracic & Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Nam Hee Park
- Department of Thoracic & Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Jong Min Song
- Department of Internal Medicine, Division of Cardiology, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - In Cheol Choi
- Department of Anesthesia, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Jee Yeon Shim
- Department of Anesthesia, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Sang Kwon Lee
- Department of Thoracic & Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Young Joo Kwon
- Department of Mechano-Informatics & Design Engineering, College of Science and Technology, Hongik University, Seoul, Korea
| | - Chang Nyung Kim
- College of Mechanical and Industrial System Engineering, Kyunghee University, Seoul, Korea
| | - Jae Won Lee
- Department of Thoracic & Cardiovascular Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea
| |
Collapse
|
20
|
Daebritz SH, Sachweh JS, Hermanns B, Fausten B, Franke A, Groetzner J, Klosterhalfen B, Messmer BJ. Introduction of a flexible polymeric heart valve prosthesis with special design for mitral position. Circulation 2003; 108 Suppl 1:II134-9. [PMID: 12970222 DOI: 10.1161/01.cir.0000087655.41288.dc] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Current heart valve prostheses are constructed mimicking the native aortic valve. Special hemodynamic characteristics of the mitral valve such as a nonaxial central inflow with creation of a left ventricular vortex have so far not been taken into account. A new polycarbonaturethane (PCU) bileaflet heart valve prosthesis with special design for the mitral position is introduced, and results of animal testing are presented. METHODS AND RESULTS After in vitro testing, 7 PCU-prostheses and 7 commercial bioprostheses (Perimount, n=4; Mosaic, n=3) were implanted in mitral position into growing Jersey calves (age 3-5 months, weight 60-97 kg) for 20 weeks. 2-Dimensional echocardiography was performed after implantation and before sacrification. Autopsy included histologic, radiographic, and electron microscopic examination of the valves. In vitro durability was proven for >15 years. After implantation 2-dimensional-echocardiography showed no relevant gradient or regurgitation of any prosthesis. Clinical course of the animals with PCU valves was excellent. In contrast, 5 of 7 calves with bioprostheses were sacrificed after 1-9 weeks because of congestive heart failure. 2-Dimensional echocardiography of the PCU valves after 20 weeks showed mild leaflet thickening with trivial regurgitation; mean gradient was 8.1+/-5.0 mm Hg (weight: 160-170 kg). The explanted PCU prostheses revealed mild calcification and no structural degeneration. All of the Perimount bioprostheses were severely calcified and degenerated after 11+/-7 weeks. One Mosaic bioprosthesis was thrombosed after 1 week, and 2 showed severe and mild-to-moderate degeneration after 4 and 22 weeks, respectively. CONCLUSIONS Polycarbonaturethane valve prostheses with special design for mitral position show excellent hemodynamic performance and durability in vivo. Calcification and structural changes are mild compared with bioprostheses. Controlled clinical studies are planned.
Collapse
Affiliation(s)
- Sabine H Daebritz
- Department of Cardiac Surgery, Ludwig-Maximilians-University, University Hospital Grosshadern, Munich, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Singla A, Lee CH. Inhibition of CEM calcification by the sequential pretreatment with ethanol and EDTA. J Biomed Mater Res A 2003; 64:706-13. [PMID: 12601783 DOI: 10.1002/jbm.a.10375] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The major object of the present study is to optimize the anticalcification activity of ethanol on bioprosthetic heart valve (BHV) calcification. We hypothesize that the chelating agent, in combination with ethanol, will synergistically prevent aortic wall calcification. Collagen-elastin matrix (CEM) was developed as a calcifiable matrix for simulating the calcification process of implantable biomaterials. The efficacy of the combination effects of ethanol and EDTA on the calcification process of CEMs was investigated by implanting them after pretreatment with various conditions of ethanol and EDTA in the rat subdermal model. The relationship between calcium concentrations and pretreatment conditions (a series vs. simultaneous, i.e., first ethanol and then EDTA in water solution, the reverse, or EDTA in ethanol) was established and the optimal condition for prevention of BHV calcification was determined. The mechanistic studies on anticalcification effects exerted by particular pretreatment sequences were also conducted using FTIR and differential scanning calorimetry (DSC). The sequential pretreatment of CEM first with ethanol and then EDTA in water solution significantly decreased the calcification rate of CEM compared the control. The percentage of prevention of calcification by the serial treatment of ethanol (80% v/v) and then EDTA in water solutions decreased, as the concentration of elastin in the CEM increased. The percentage of preventing calcification was 42%, 28.6%, and 22.9% for CEM containing collagen and elastin ratios of 90:10, 50:50, 20:80, respectively. These results indicate that elastin is the major regulatory component of BHV calcification, and preventive effects on calcification increased only when CEM were pretreated with first ethanol and then EDTA in water solution. Moreover, the sequential effect is more apparent in the matrix of less elastin content, which is close to the physiological range. The sequential inhibitory effects of ethanol and EDTA could occur due to the distinct separate actions of each agent, thereby achieving a relatively greater inhibition of calcification.
Collapse
Affiliation(s)
- Anuj Singla
- College of Pharmacy, The University of Missouri, 5005 Rockhill Road, Kansas City, Missouri 64110, USA
| | | |
Collapse
|
22
|
Singla A, Lee CH. Effect of elastin on the calcification rate of collagen-elastin matrix systems. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 2002; 60:368-74. [PMID: 11920659 DOI: 10.1002/jbm.10077] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The role of elastin in the aortic wall calcification and involved mechanisms were investigated. The major hypothesis of this work is that elastin is one of the major components to regulate calcification of bioprosthetic heart valve (BHV). The relationship between the elastin content and the calcification rate of the aortic wall was established using collagen-elastin matrices (CEM) made of varying ratios of collagen and elastin (90 and 10, 50 and 50, and 20 and 80). Biophysical characterization of CEM was performed by water content measurement and the tensile strength test. The conformational changes of the calcifiable matrix were evaluated as a function of elastin content using Fourier transform infrared (FTIR) spectroscopy. The calcium contents in CEM implanted in the rat subcutaneous model for 7 days were measured using atomic absorption (AA) spectroscopy. As the concentration of elastin in CEM increased from 10 to 80%, the total amount of calcium accumulated in CEM also increased. The calcium level in CEM containing the collagen and an elastin ratio of 20:80 was 20.16 +/- 0.70 microg/mg compared with 1.96 +/- 0.04 microg/mg in CEM containing the collagen and an elastin ratio of 90:10. The calcification rate of CEM pretreated with ethanol increased, as the elastin concentration in the CEM. However, the calcification rate of CEM pretreated with ethanol is significantly lower than that of the untreated control. The permeation rate of ethanol through CEM with the collagen and an elastin ratio of 20:80 (0.37 +/- 0.13 mmol/cm(2)/h) is significantly smaller than that through CEM with 90:10 (0.94 +/- 0.27 mmol/cm(2)/h). These results indicate that elastin has a significant role in tissue calcification and that elastin's resistance to ethanol penetration partially contributes less effectiveness of ethanol on aortic wall calcification.
Collapse
Affiliation(s)
- Anuj Singla
- College of Pharmacy, The University of Missouri-Kansas City, Missouri 64110, USA
| | | |
Collapse
|
23
|
Garcia Páez JM, Jorge-Herrero E, Carrera A, Millán I, Rocha A, Calero P, Cordón A, Salvador J, Sainz N, Méndez J, Castillo-Olivares JL. Chemical treatment and tissue selection: factors that influence the mechanical behaviour of porcine pericardium. Biomaterials 2001; 22:2759-67. [PMID: 11545310 DOI: 10.1016/s0142-9612(01)00019-9] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Calcification and mechanical failure are the major causes of the loss of cardiac bioprostheses. The chemical treatments used to stabilize the tissue employed are considered to play a fundamental role in the development of these two phenomena, although the problem is multifactorial and the underlying causes are yet to be fully identified. Currently, there is an ongoing search for chemical treatments capable of reducing or eliminating the process of calcification while preserving the mechanoelastic characteristics of the tissue. One of the approaches to this effort is the elimination of the phospholipid component from the biological tissue employed in prosthesis construction. There is evidence that this component may be responsible for the precipitation of calcium salts. The present study compares two delipidating chemical treatments involving chloroform/methanol and sodium dodecyl sulfate (SDS) with the use of glutaraldehyde (GA) alone. For this purpose, porcine pericardial tissue was subjected to tensile strength testing employing a hydraulic simulator. A total of 234 samples were studied 90 treated with GA, 72 treated with chloroform/methanol and 72 treated with SDS. The mean breaking strength was significantly higher in the samples treated with GA (between 43.29 and 63.01 MPa) when compared with those of tissue treated with chloroform/methanol (29.92-42.30 MPa) or with SDS (13.49-19.06 MPa). In a second phase of the study, selection criteria based on morphological and mechanical factors were applied to the pericardial membranes employing a system of paired samples. The mathematical analysis of the findings in one fragment will aid in determining the mechanical behavior of its adjacent twin sample. In conclusion, the anticalcification chemical treatments tested in the experimental model conferred a lesser mechanical resistance than that obtained with GA. On the other hand, the utilization of paired samples was found to be useful in the prediction of the mechanical behavior of porcine pericardial tissue. Nevertheless, in order for our method of selection to be considered the most adequate approach, it will be necessary to validate these findings in dynamic studies involving a real, functional model.
Collapse
Affiliation(s)
- J M Garcia Páez
- Services of Preventive Medicine, Puerta de Hierro Clinic, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics, such as biodegradability and weak antigenecity, made collagen the primary resource in medical applications. The main applications of collagen as drug delivery systems are collagen shields in ophthalmology, sponges for burns/wounds, mini-pellets and tablets for protein delivery, gel formulation in combination with liposomes for sustained drug delivery, as controlling material for transdermal delivery, and nanoparticles for gene delivery and basic matrices for cell culture systems. It was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. This article reviews biomedical applications of collagen including the collagen film, which we have developed as a matrix system for evaluation of tissue calcification and for the embedding of a single cell suspension for tumorigenic study. The advantages and disadvantages of each system are also discussed.
Collapse
Affiliation(s)
- C H Lee
- Department of Pharmaceutics, College of Pharmacy, The University of Missouri-Kansas City, 5005 Rockhill Rd, Katz Bdg #108, Kansas City, MO 64110, USA.
| | | | | |
Collapse
|
25
|
Duarte IG, MacDonald MJ, Cooper WA, Schmarkey SL, Gott JP, Brown WM, Vinten-Johansen J, Guyton RA. In vivo hemodynamic, histologic, and antimineralization characteristics of the Mosaic bioprosthesis. Ann Thorac Surg 2001; 71:92-9. [PMID: 11216817 DOI: 10.1016/s0003-4975(00)01989-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
BACKGROUND Performance of bioprosthetic valves is limited by tissue degeneration due to calcification with reduced performance and longevity. The Mosaic bioprosthetic valve (Medtronic Heart Valves, Inc, Minneapolis, MN) combines zero pressure fixation, antimineralization properties of alpha-amino oleic acid (AOA), and a proven stent design. We tested the hypothesis that AOA treatment of Mosaic valves improves hemodynamics, antimineralization properties, and survival in a chronic ovine model. METHODS Mitral valves were implanted in juvenile sheep with Mosaic valves with AOA treatment (n = 8) or without AOA treatment (non-AOA, n = 8), or Hancock I (HAN, n = 4) tissue valves, and explanted at 20 postoperative weeks. RESULTS Survival was equivalent in AOA and non-AOA (140 +/- 0.4 and 129 +/- 30 days), but was significantly less in HAN (82 +/- 35). Leaflet calcium (microgCa/mg tissue) was less in AOA (9.6 +/- 13.9; p < 0.05 versus non-AOA and HAN) than non-AOA (96.3 +/- 63.8) and HAN (130.8 +/- 43.2). Explant valve orifice area (cm2) was significantly preserved in the AOA group compared with the non-AOA group (1.5 +/- 0.7 vs 0.8 +/- 0.3; p < 0.05 versus non-AOA and HAN). CONCLUSIONS We conclude that AOA treatment of Mosaic valves reduces leaflet calcification and valve gradient in juvenile sheep, and that the Mosaic design and fixation features may offer survival advantages that must be confirmed in extended trials.
Collapse
Affiliation(s)
- I G Duarte
- Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center, Crawford Long Hospital, Emory University School of Medicine, Atlanta, Georgia 30365, USA
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Boughner DR, Thornton M, Dunmore-Buyze J, Holdsworth DW. The radiographic quantitation of aortic valve calcification: implications for assessing bioprosthetic valve calcification in vitro. Physiol Meas 2000; 21:409-16. [PMID: 10984208 DOI: 10.1088/0967-3334/21/3/306] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Calcification of natural aortic and bioprosthetic heart valves is a poorly understood phenomenon that results in valvular obstruction and tissue failure. We describe a non-destructive quantitative computed microtomographic (QCT) technique for determining both calcium content and local calcium distribution within explanted valves. As a reference standard, a dual-energy x-ray absorptiometry (DEXA) system with an accuracy demonstrated to be within 1% of the true calcium mass of test material was used to obtain the total calcium content of 24 human aortic valve cusps recovered at autopsy from patients aged 51-80 years. These cusps were then scanned using our unique volume QCT scanner, with multiple x-ray projections acquired by rotating the explanted tissue through a single axis of rotation. A three-dimensional cross-sectional map was reconstructed for each cusp. Voxel size was 0.003 mm3 and a calibration phantom was used to calculate calcium content. The minimum detection limit for calcium mass was 1 mg within the whole cusp. The DEXA and QCT scans were compared with respect to total calcium content, which ranged from 0 to 15 mg. An excellent correlation between the two independent techniques was demonstrated with an r2 value of 0.94 (p < 0.001). Non-destructive microtomographic CT scanning provided excellent volumetric density measurements, with quantitative 3D images permitting an assessment of any individual area of the cusp for calcium content and spatial distribution. This new approach to valve tissue analysis allows for subsequent histologic assessment.
Collapse
Affiliation(s)
- D R Boughner
- The John P Robarts Research Institute, London, Canada.
| | | | | | | |
Collapse
|
27
|
Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1999; 47:439-65. [PMID: 10497280 DOI: 10.1002/(sici)1097-4636(19991215)47:4<439::aid-jbm1>3.0.co;2-o] [Citation(s) in RCA: 274] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Substitute heart valves composed of human or animal tissues have been used since the early 1960s, when aortic valves obtained fresh from human cadavers were transplanted to other individuals as allografts. Today, tissue valves are used in 40% or more of valve replacements worldwide, predominantly as stented porcine aortic valves (PAV) and bovine pericardial valves (BPV) preserved by glutaraldehyde (GLUT) (collectively termed bioprostheses). The principal disadvantage of tissue valves is progressive calcific and noncalcific deterioration, limiting durability. Native heart valves (typified by the aortic valve) are cellular and layered, with regional specializations of the extracellular matrix (ECM). These elements facilitate marked repetitive changes in shape and dimension throughout the cardiac cycle, effective stress transfer to the adjacent aortic wall, and ongoing repair of injury incurred during normal function. Although GLUT bioprostheses mimic natural aortic valve structure (a) their cells are nonviable and thereby incapable of normal turnover or remodeling ECM proteins; (b) their cuspal microstructure is locked into a configuration which is at best characteristic of one phase of the cardiac cycle (usually diastole); and (c) their mechanical properties are markedly different from those of natural aortic valve cusps. Consequently, tissue valves suffer a high rate of progressive and age-dependent structural valve deterioration resulting in stenosis or regurgitation (>50% of PAV overall fail within 10-15 years; the failure rate is nearly 100% in 5 years in those <35 years old but only 10% in 10 years in those >65). Two distinct processes-intrinsic calcification and noncalcific degradation of the ECM-account for structural valve deterioration. Calcification is a direct consequence of the inability of the nonviable cells of the GLUT-preserved tissue to maintain normally low intracellular calcium. Consequently, nucleation of calcium-phosphate crystals occurs at the phospholipid-rich membranes and their remnants. Collagen and elastin also calcify. Tissue valve mineralization has complex host, implant, and mechanical determinants. Noncalcific degradation in the absence of physiological repair mechanisms of the valvular structural matrix is increasingly being appreciated as a critical yet independent mechanism of valve deterioration. These degradation mechanisms are largely rationalized on the basis of the changes to natural valves when they are fabricated into a tissue valve (mentioned above), and the subsequent interactions with the physiologic environment that are induced following implantation. The "Holy Grail" is a nonobstructive, nonthrombogenic tissue valve which will last the lifetime of the patient (and potentially grow in maturing recipients). There is considerable activity in basic research, industrial development, and clinical investigation to improve tissue valves. Particularly exciting in concept, yet early in practice is tissue engineering, a technique in which an anatomically appropriate construct containing cells seeded on a resorbable scaffold is fabricated in vitro, then implanted. Remodeling in vivo, stimulated and guided by appropriate biological signals incorporated into the construct, is intended to recapitulate normal functional architecture.
Collapse
Affiliation(s)
- F J Schoen
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115, USA
| | | |
Collapse
|
28
|
Mako WJ, Shah A, Vesely I. Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1999; 45:209-13. [PMID: 10397978 DOI: 10.1002/(sici)1097-4636(19990605)45:3<209::aid-jbm8>3.0.co;2-n] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
When evaluating the efficacy of new antimineralization treatments for bioprosthetic heart valves, subcutaneous implantation in a rat model often is used as an initial test. Although this model is widely used, there still are many aspects of its implementation that have not been investigated. To further investigate several parameters that may affect mineralization in the subcutaneous rat model, portions of glutaraldehyde-treated porcine aortic valve cusps were implanted both ventrally and dorsally into 21-day-old male Sprague-Dawley rats. Cusp quadrants were explanted at 1,2, and 3 weeks postimplantation and the calcium levels determined by atomic absorption spectroscopy. The objective of this study was to determine whether or not different implant locations and/or regions of the cusps affect the degree to which tissue mineralizes in the subcutaneous rat model. A total of 270 tissue specimens were examined. While the specific portion of the cusp implanted did not significantly affect the degree of mineralization, dorsal implantation resulted in significantly more mineralization than abdominal implantation (p = 0.007). As expected, longer implantation time was associated with greater calcification (p = 0.0001). The results of this study indicate that inconsistent placement of tissues in the rat subcutaneous implant model can result in significant differences in the degree of mineralization.
Collapse
Affiliation(s)
- W J Mako
- The Department of Biomedical Engineering, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
| | | | | |
Collapse
|
29
|
Abstract
Cardiac valve bioprostheses are assessed in terms of their present and future clinical utility. The problems concerning durability basically involve early failure due to tears in the valve leaflets and late failure mainly associated with calcification of the biological tissue. New strategies for selection and chemical treatment of the biomaterials employed are analyzed, and the available knowledge regarding their mechanical behavior is reviewed. It is concluded that the durability of these devices, and thus their successful use in the future, depends on the knowledge of the interactions among the different biomaterials of which they are composed, the development of new materials, and the engineering design applied in their construction.
Collapse
Affiliation(s)
- J M García Páez
- Servicio de Cirugía Experimental Clínica Puerta de Hierro, Madrid, Spain
| | | |
Collapse
|
30
|
Walther T, Falk V, Autschbach R, Diegeler A, Rauch T, Weigl C, Günther B, van Son JA, Mohr FW. Comparison of different anticalcification treatments for stentless bioprostheses. Ann Thorac Surg 1998; 66:S249-54. [PMID: 9930458 DOI: 10.1016/s0003-4975(98)00985-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
BACKGROUND New anticalcificant treatments have been developed because tissue calcification is a major contributing factor for bioprosthetic valve failure. METHODS Aortic valve leaflet and aortic root tissue samples from stentless bioprostheses treated with No-React (Biocor, Belo Horizonte, Brazil), AOA (Medtronic freestyle, Minneapolis, MN), and BiLinx (St. Jude Medical, St. Paul, MN) were compared to a control group by subcutaneous implantation in 60 male weanling Sprague-Dawley rats. RESULTS Calcium levels were in the range of 0.3 to 2.2 mg/g dry tissue at 3 and 12 weeks in all three treated aortic valve leaflet implants. The BiLinx treatment proved anticalcificant effectiveness on aortic root samples as well. There were statistically significant differences for valve leaflet tissue samples: No-React = AOA < BiLinx < < Control and for aortic root tissue samples: BiLinx < < AOA < Control = No-React. CONCLUSION Calcification of aortic valve leaflets was significantly reduced by all new anticalcificant treatments. Inhibition of cellular calcification (BiLinx) resulted in additional reduction of aortic root calcification. Maximum anticalcificant properties upon both leaflet and aortic root is important as these are considered a functional unit in stentless bioprostheses.
Collapse
Affiliation(s)
- T Walther
- Department of Cardiac Surgery, Heart Center, University of Leipzig, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1998; 42:30-7. [PMID: 9740004 DOI: 10.1002/(sici)1097-4636(199810)42:1<30::aid-jbm5>3.0.co;2-p] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The effectiveness of ethanol pretreatment on preventing calcification of glutaraldehyde-fixed porcine aortic bioprosthetic heart valve (BPHV) cusps was previously demonstrated, and the mechanism of action of ethanol was attributed in part to both lipid removal and a specific collagen conformational change. In the present work, the effect of ethanol pretreatment on BPHV aortic wall calcification was investigated using both rat subdermal and sheep circulatory implants. Ethanol pretreatment significantly inhibited calcification of BPHV aortic wall, but with less than complete inhibition. The maximum inhibition of calcification of BPHV aortic wall was achieved using an 80% ethanol pretreatment; calcium levels were 71.80+/-8.45 microg/mg with 80% ethanol pretreatment compared to the control calcium level of 129.90+/-7.24 microg/mg (p = 0.001). Increasing the duration of ethanol exposure did not significantly improve the inhibitory effect of ethanol on aortic wall calcification. In the sheep circulatory implants, ethanol pretreatment partly prevented BPHV aortic wall calcification with a calcium level of 28.02+/-4.42 microg/mg compared to the control calcium level of 56.35+/-6.14 microg/mg (p = 0.004). Infrared spectroscopy (ATR-FTIR) studies of ethanol-pretreated BPHV aortic wall (vs. control) demonstrated a significant change in protein structure due to ethanol pretreatment. The water content of the aortic wall tissue and the spin-lattice relaxation times (T1) as assessed by proton nuclear magnetic resonance spectroscopy did not change significantly owing to ethanol pretreatment. The optimum condition of 80% ethanol pretreatment almost completely extracted both phospholipids and cholesterol from the aortic wall; despite this, significant calcification occurred. In conclusion, these results clearly demonstrate that ethanol pretreatment is significantly but only partially effective for inhibition of calcification of BPHV aortic wall and this effect may be due in part to lipid extraction and protein structure changes caused by ethanol. It is hypothesized that ethanol pretreatment may be of benefit for preventing bioprosthetic aortic wall calcification only in synergistic combination with another agent.
Collapse
Affiliation(s)
- C H Lee
- Department of Pediatrics and Communicable Diseases, The University of Michigan, Ann Arbor 48109, USA
| | | | | | | | | | | | | |
Collapse
|
32
|
Salerno CT, Pederson TS, Ouyang DW, Bolman RM, Bianco RW. Chronic evaluation of orthotopically implanted bileaflet mechanical aortic valves in adult domestic sheep. J INVEST SURG 1998; 11:341-7. [PMID: 9827651 DOI: 10.3109/08941939809032210] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
This study was intended to develop a technically feasible and reproducible model for chronic hemodynamic and mechanical evaluation of orthotopically implanted bileaflet mechanical aortic valves in adult domestic sheep. Three adult sheep (mean age 22 weeks, mean weight 76 kg) underwent aortic valve replacement using 19-mm bileaflet aortic valves. Standard cardiopulmonary bypass techniques were followed, including mild hemodilution, systemic hypothermia, and cardioplegic arrest. After performing a left fourth intercostal thoracotomy, the valves were placed using interrupted 3-0 Ticron (Davis + Geck) inverted mattress sutures through a transverse aortotomy. The average cardiopulmonary bypass time was 58+/-1 min. No chronic anticoagulation was used. There were no surgical complications. All three animals (100%) remained clinically well until elective sacrifice after postoperative day 150. The average cardiac output for the animals at sacrifice was 3.8+/-1.0 L/min. The mean aortic ejection velocity was 304.7+/-47.3 cm/s and the mean pressure gradient was 24.6+/-6.7 mm Hg. There was no clinically significant thrombus formation or paravalvular leaks. Thus, we have demonstrated that it is technically feasible to orthotopically implant mechanical aortic valves in sheep. There are several features that contribute to the success of this model, including use of a transverse aortotomy, adequate de-airing, and the use of mild hemodilution during bypass. We believe that this model is reproducible and can be used to study other valve designs. In addition, this model allows for site-specific preclinical assessment of new or modified mechanical heart valves.
Collapse
Affiliation(s)
- C T Salerno
- University of Minnesota, Department of Surgery, Minneapolis 55455, USA.
| | | | | | | | | |
Collapse
|
33
|
Vyavahare NR, Hirsch D, Lerner E, Baskin JZ, Zand R, Schoen FJ, Levy RJ. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1998; 40:577-85. [PMID: 9599034 DOI: 10.1002/(sici)1097-4636(19980615)40:4<577::aid-jbm9>3.0.co;2-c] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Clinical usage of bioprosthetic heart valves (BPHVs) fabricated from glutaraldehyde-pretreated porcine aortic valves is restricted due to calcification-related failure. We previously reported a highly efficacious ethanol pretreatment of BPHVs for the prevention of cuspal calcification. The aim of the present study is to extend our understanding of the material changes brought about by ethanol and the relationship of these material effects to the ethanol pretreatment anticalcification mechanism. Glutaraldehyde-crosslinked porcine aortic valve cusps (control and ethanol-pretreated) were studied for the effects of ethanol on tissue water content and for spin-lattice relaxation times (T1) using solid state proton NMR. Cusp samples were studied for protein conformational changes due to ethanol by ATR-FTIR spectroscopy. The changes in cuspal tissue-cholesterol (in vitro) interactions also were studied. Cusp material stability was assessed in terms of residual glutaraldehyde content and collagenase degradation. Water content of the cusp samples was decreased significantly due to ethanol pretreatment. The cuspal collagen conformational changes (per infrared spectroscopy) brought about by ethanol pretreatment were persistent even after rat subdermal implantation of cusp samples for 7 days. In vitro cholesterol uptake by cusps was greatly reduced as a result of ethanol pretreatment. Ethanol pretreatment of cusps also resulted in increased resistance to collagenase digestion. Cuspal glutaraldehyde content was not changed by ethanol pretreatment. We conclude that ethanol pretreatment of bioprosthetic heart valve cusps causes multi-component effects on the tissue/material and macromolecular characteristics, which partly may explain the ethanol-pretreatment anticalcification mechanism.
Collapse
Affiliation(s)
- N R Vyavahare
- Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, USA
| | | | | | | | | | | | | |
Collapse
|
34
|
Ouyang DW, Salerno CT, Pederson TS, Bolman RM, Bianco RW. Long-term evaluation of orthotopically implanted stentless bioprosthetic aortic valves in juvenile sheep. J INVEST SURG 1998; 11:175-83. [PMID: 9743485 DOI: 10.3109/08941939809098032] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The aim of this study was to develop a technically feasible and reproducible model for chronic evaluation of stentless bioprosthetic aortic valves implanted orthotopically using juvenile domestic sheep. This report summarizes the results of a study conducted to assess orthotopically placed 19-mm stentless aortic bioprosthetic valves. Twenty-seven juvenile sheep underwent aortic valve replacement. Standard cardiopulmonary bypass techniques were followed. The average cardiopulmonary bypass time was 73 min. No chronic anticoagulation was used. There were two deaths (7%) due to surgical complications. In the remaining 25 experiments, 11 animals (41%) died prior to the scheduled sacrifice on postoperative day 150. One early death occurred due to coccidiomycosis infection, one due to technical error, one due to pulmonary embolus, four due to prosthetic annular size disproportion, and four due to thrombi. The remaining 14 animals (52%) underwent left and right heart catheterization, angiography, echocardiography, and sacrifice after postoperative day 150. The average weight of the sheep at elective sacrifice was 60 kg (mean weight gain 12.5 kg). The average cardiac output for the sacrificed animals was 5.1 L/min. The mean velocity of blood across the aortic valve for the sacrificed animals was 317 cm/s and the mean pressure gradient was 26.2 mm Hg. Two features suggest that this model may have broad application. First, we have demonstrated that it is technically feasible to evaluate orthotopically placed stentless bioprosthetic aortic valves in growing sheep. Second, the aortic root size of the juvenile sheep allows for implantation and evaluation of a human size aortic valve (19 mm). We believe that this model is reproducible and can be used to study stentless valve designs.
Collapse
Affiliation(s)
- D W Ouyang
- Department of Surgery, University of Minnesota, Minneapolis 55455, USA
| | | | | | | | | |
Collapse
|
35
|
Chanda J, Kuribayashi R, Abe T. Valved conduit in the descending thoracic aorta in juvenile sheep: a useful, cost-effective model for accelerated calcification study in systemic circulation. Biomaterials 1997; 18:1317-21. [PMID: 9307222 DOI: 10.1016/s0142-9612(97)00065-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
To evaluate the efficacy of any new anticalcificant in bioprostheses, a cost-effective and easy circulatory model is proposed. Calcification of 0.625% glutaraldehyde-treated porcine aortic valved conduits implanted in the descending thoracic aorta in 11 juvenile sheep for 5 months was compared with that of leaflets of glutaraldehyde-treated porcine aortic valve implanted subcutaneously in 3-week-old male Wistar rats for the same period. Cusps of valved conduits (Ca, 205.41 +/- 16.24 mg g(-1)) in sheep and aortic valve leaflets in rats (Ca, 235.21 +/- 45.25 mg g(-1)) (P = 0.0299) were severely calcified. Morphological characteristics of calcification of all explants were virtually identical. This model provides a model for testing calcification that lies between the subcutaneous weanling rat model and orthotopic whole valve replacement on the left side of the heart. It is less costly and easier to perform than the latter, but does provide exposure to the bloodstream under pressure, which the rat model does not.
Collapse
Affiliation(s)
- J Chanda
- Department of Cardiovascular Surgery, Akita University School of Medicine, Japan
| | | | | |
Collapse
|
36
|
Chanda J, Kuribayashi R, Abe T, Sekine S, Shibata Y, Yamagishi I. Is the dog a useful model for accelerated calcification study of cardiovascular bioprostheses? Artif Organs 1997; 21:391-5. [PMID: 9129770 DOI: 10.1111/j.1525-1594.1997.tb00735.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Chitosan posttreatment has been shown to be effective in prevention of calcification of the glutaraldehyde treated bovine pericardium when implanted subdermally in rats for 12 weeks. The efficacy of chitosan posttreatment in complete calcium mitigation of the glutaraldehyde treated porcine aortic valves implanted in the right side of the heart in dogs was well-documented in our previous study. In this study, an attempt has been made to evaluate the merit of the chitosan posttreatment in prevention of calcification of the glutaraldehyde (GA) treated porcine aortic valved conduits in the systemic circulation in dogs for a period of 5 months. Eleven mongrel dogs underwent left thoracotomy. Porcine aortic valved conduits treated with 0.625% GA (n = 5) and GA-chitosan (n = 6) were implanted in the descending thoracic aortas of the dogs for 5 months. Gross histological observations showed no calcification in either the 0.625% GA treated or in the GA-chitosan treated valved conduits at 5 months. This was confirmed by results of quantitative analyses for calcium in each explant. There was no significant difference in calcium content between the GA only (Ca, 0.43 +/- 0.26 mg/g) and GA-chitosan treated (Ca, 0.51 +/- 0.19 mg/g; p = 0.5959) valved conduits. This study suggests that the dog is not a suitable model for evaluating the efficacy of a calcium mitigating agent in bioprostheses implanted in systemic circulation.
Collapse
Affiliation(s)
- J Chanda
- Department of Cardiovascular Surgery, Akita University School of Medicine, Japan.
| | | | | | | | | | | |
Collapse
|
37
|
Jorge-Herrero E, Fernández P, Escudero C, de la Torre N, Zurita M García Páez JM, Castillo-Olivares JL. Influence of stress on calcification of delipidated bovine pericardial tissue employed in construction of cardiac valves. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1996; 30:411-5. [PMID: 8698705 DOI: 10.1002/(sici)1097-4636(199603)30:3<411::aid-jbm16>3.0.co;2-m] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Since the development of cardiac bioprostheses, numerous chemical treatments have been assayed to prevent mineralization. The effectiveness of chemical treatments that eliminate lipids from the tissue was tested by combining two models. First, handmade bovine pericardial bioprostheses, subjected to chemical treatment with chloroform/ methanol and glutaraldehyde or treated with glutaraldehyde alone for use as controls, were subjected to mechanical stress in a heart valve, accelerated wear tester (100 x 10(6) consecutive cycles). Then, the bioprostheses were unstitched and tissue samples were taken from the portion subjected to maximal stress (P1) and from that surrounding the sewing ring, which had not been subjected to mechanical stress (P2), for subcutaneous implantation. After 21 and 60 days of implantation, we observed calcification of the samples subjected to mechanical stress, even after delipidating treatment, with no significant differences with respect to the control group. However, the treated samples from the portion not subjected to mechanical stress presented a slighter accumulation of calcium after 60-day implantation (5.60 +/- 3.09 mg Ca2 +/g dry weight of tissue) versus the control group (47.17 +/- 20.4 mg Ca2+/g dry weight of tissue), the difference of which was statistically significant (p < 0.01). At the time of these medium-term studies, marked calcification was observed in tissue subjected to delipidating treatment in the zones that underwent mechanical stress.
Collapse
Affiliation(s)
- E Jorge-Herrero
- Servicio de Cirugía Experimental, Clínica Puerta de Hierro, UniversidadAAutónoma de Madrid, Spain
| | | | | | | | | | | |
Collapse
|
38
|
Coury AJ, Levy RJ, Ratner BD, Schoen FJ, Williams DF, Williams RL. Degradation of Materials in the Biological Environment. Biomater Sci 1996. [DOI: 10.1016/b978-012582460-6/50009-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Abstract
Alternative conduits must be chosen when autologous grafts are not available for coronary artery bypass grafting (CABG). Viable grafts do not always have perfect characteristics for CABG, and homologous venous conduits have been used with unsatisfactory results. Many small caliber vascular grafts used for coronary bypass conduits have been developed in the past, but most of them have failed except in rare instances. In this paper the current problems in available conduits, new technologies for improvement, animal models, and possibilities for the future for CABG conduits are discussed.
Collapse
Affiliation(s)
- Y Tomizawa
- Department of Cardiothoracic Surgery, Stanford University School of Medicine, California, USA
| |
Collapse
|
40
|
Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic valves Implanted as orthotopic mitral valve replacements in juvenile sheep. J Thorac Cardiovasc Surg 1994. [DOI: 10.1016/s0022-5223(94)70186-5] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Jorge-Herrero E, Fernández P, de la Torre N, Escudero C, García-Páez JM, Buján J, Castillo-Olivares JL. Inhibition of the calcification of porcine valve tissue by selective lipid removal. Biomaterials 1994; 15:815-20. [PMID: 7986946 DOI: 10.1016/0142-9612(94)90036-1] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Since the development of cardiac prostheses, numerous chemical treatments have been assayed to prevent the process of their mineralization, causing 60% of the failures. The effect of the extraction of lipids from the tissue employed in porcine valves is assessed in a model of subcutaneous implantation in rats. Tissue from aortic and pulmonary porcine valves was treated with chloroform-methanol and 0.625% glutaraldehyde and was implanted into young rats for periods of 21 and 60 d. The calcium accumulated was then quantified by atomic absorption. The effectiveness of this treatment is demonstrated by the detection of much lower calcium values than in the control group. For aortic valve tissue, the values obtained were 40.5 and 188.1 micrograms Ca2+/mg dry weight of tissue for implantation times of 21 and 60 d, respectively, versus 5.48 and 1.4 micrograms Ca2+/mg dry weight of tissue for the same tissue treated with chloroform-methanol. The values obtained with pulmonary valve tissue were very similar: 72.46 and 108.06 micrograms Ca2+/mg dry weight tissue versus 0.67 and 0.80 micrograms Ca2+/mg dry weight tissue for implantation periods of 21 and 60 d, respectively. Thus, phospholipids may be totally or partially responsible for the calcification of the porcine valve tissue employed in the construction of cardiac bioprostheses.
Collapse
Affiliation(s)
- E Jorge-Herrero
- Service of Experimental Surgery, Clinica Puerta de Hierro, Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
42
|
Abstract
Significant opportunities and challenges exist in the creation and characterization of biomaterials. Materials have been designed for contact with blood, as replacements for soft and hard tissues, as adhesives, and as dental materials. Current methods of synthesis and characterization of these materials are outlined. Approaches for controlling the interface between tissue and biomaterials and ways in which the engineered materials may contribute to medicine are considered.
Collapse
Affiliation(s)
- N A Peppas
- School of Chemical Engineering, Purdue University, West Lafayette, IN 47907-1283
| | | |
Collapse
|
43
|
Abstract
All types of contemporary cardiac valve substitutes suffer deficiencies and complications that limit their success. Mechanical and bioprosthetic valves are intrinsically obstructive, especially in small sizes. Mechanical valves are associated with thromboembolic problems; the chronic anticoagulation used in virtually all mechanical valve recipients causes hemorrhage in some. Calcification limits the success of porcine and pericardial bioprostheses, allograft valves, and the yet experimental trileaflet polymeric prostheses. The predominant mechanism of calcification in porcine, pericardial, and allograft valves is cell mediated, being nucleated at the membranes and in organelles of the transplanted cells. In polymeric leaflet valves, calcification is both extrinsic (in adherent thrombus) and intrinsic (subsurface and acellular in the solid elastomer). Nevertheless, except for a few notable exceptions, contemporary mechanical valves are durable. Other important potential complications of prosthetic and bioprosthetic valves include paravalvular leak, endocarditis, or extrinsic interference with function. Moreover, aortic valvular allografts undergo progressive noncalcific degeneration, tearing, sagging, and/or retraction. Studies of retrieved long-term cryopreserved allograft explants demonstrate severe degeneration, with distortion of normal architectural detail, loss of endothelial and deep connective tissue cells, and variable inflammatory cellularity. Thus, they are morphologically nonviable valves, whose structural basis for function seems primarily related to the largely preserved collagen, and they are unlikely to have the capacity to grow, remodel, or exhibit active metabolic functions. Since calcification intrinsic to the cusps is the major pathologic process necessitating bioprosthetic valve reoperations, efforts to prevent formation of mineral deposits are active.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- F J Schoen
- Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts 02115
| | | |
Collapse
|
44
|
Tan WM, Loke WK, Tan BL, Wee A, Khor E, Goh KS. Trivalent metal ions in the prevention of calcification in glutaraldehyde treated biological tissues. Is there a chemical correlation? Biomaterials 1993; 14:1003-7. [PMID: 8286666 DOI: 10.1016/0142-9612(93)90193-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The influence of chemical factors on trivalent metal ions in the prevention of calcification of glutaraldehyde treated biological tissue has been explored. The results indicate that the chemical link lies in the hard character of the trivalent metal ions. Metal ions with the hardest character appear to have the best chance of reacting with oxygen atoms of the phosphate groups at nucleation sites of hydroxyapatite. This disrupts the nucleation and thus prevents calcification in glutaraldehyde treated biological tissue.
Collapse
Affiliation(s)
- W M Tan
- Department of Chemistry, National University of Singapore, Kent Ridge
| | | | | | | | | | | |
Collapse
|
45
|
|
46
|
Flomenbaum MA, Schoen FJ. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1993. [DOI: 10.1016/s0022-5223(19)33860-7] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|